Treatment

Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
OBJECTIVES: Many patients with rheumatoid arthritis (RA) require treatment with tumour necrosis factor inhibitor (TNFi) to reach …
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Stavland Lexberg, Tor Magne Madland, Hallvard Fremstad, Christian A. Høili, Gunnstein Bakland, Cristina Spada, Hilde Haukeland, Inger Myrnes Hansen, Ellen Moholt, Till Uhlig, Daniel H. Solomon, Désirée van der Heijde, Tore K. Kvien, Espen A. Haavardsholm
Cite DOI
Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study
OBJECTIVE: When initiating a new therapy in patients with rheumatoid arthritis (RA), current treatment recommendations suggest …
Vibeke Norvang, Joseph Sexton, Eirik K. Kristianslund, Inge C. Olsen, Till Uhlig, Gunnstein Bakland, Frode Krøll, Erik Rødevand, Ada Wierød, Tore K. Kvien, Josef S. Smolen, Daniel Aletaha, Espen A. Haavardsholm
Cite DOI
Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register
OBJECTIVES: Tumour necrosis factor-α inhibitor (TNFi) treatment has been shown to reduce the rates of anterior uveitis (AU) in patients …
Elisabeth Lie, Ulf Lindström, Tatiana Zverkova-Sandström, Inge C. Olsen, Helena Forsblad-d'Elia, Johan Askling, Meliha C. Kapetanovic, Lars Erik Kristensen, Lennart T. H. Jacobsson
Cite DOI